State and Federal Developments
Resources that reflect developments regarding federal and state responses to the opioid epidemic, such as a webinar regarding 2019 Part D edits related to opioids and information about National Take Back Day on April 27.
- Opioid Analgesic REMS
- National Drug Take Back Day (DEA)
- Reducing Opioid Misuse Letter to Providers (CMS)
- 2019 Medicare Part D Opioid Policies: Information for Pharmacies (Tip Sheet) (a webinar is also available) (CMS)
- Opioid Prescribing by Specialty and Volume in the U.S. (CDC)
- Surgeon General's Spotlight on Opioids: Facing Addiction in America
- Help, Resources and Information, National Opioid Crisis (HHS)
- HEAL Initiative Research Plan (NIH)
- Surgeon General's Advisory on Naloxone and Opioid Overdose (April 2018)
- DEA 360 Strategy
- Opioids (Agency for Health Research and Quality)
- White House: The Opioid Crisis
- Naloxone Access in Community Pharmacies (National Alliance of State Pharmacy Associations)
- The Surgeon General's Report on Alcohol, Drugs, and Health - Facing Addiction in America (November 2016)
- National Pain Strategy (HHS)
- Preventing the Consequences of Opioid Overdose: Understanding Naloxone Access Laws (SAMHSA)
- National and state treatment need and capacity for opioid antagonist medication-assisted treatment
- Fact Sheet – FDA Opioids Action Plan
- Prescription Drug Time and Dosage Limit Laws (CDC)
- The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse (CMS)
- State Laws on Prescription Drug Abuse and Misuse (CDC)